SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Welcure Drugs & Pharmaceuticals informs about newspaper publication

08 Aug 2025 Evaluate
Welcure Drugs & Pharmaceuticals has informed that in compliance with SEBI (Listing Obligation and Disclosure Requirement), Regulation 2015 the company has made advertisement in Newspaper of Standalone Unaudited Financial Results of Quarter ended June 30, 2025 of Welcure Drugs & Pharmaceuticals. In this regard it has enclosed newspaper clipping and oblique. 

The above information is a part of company’s filings submitted to BSE.

Welcure Drugs&Pharma Share Price

0.35 0.01 (2.94%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 218.50
Adani Enterprises 2129.55
Amrapali Industries 17.34
Rashi Peripheral 425.55
PDS 289.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×